11:33 AM EDT, 03/22/2024 (MT Newswires) -- Genetic Technologies ( GENE ) shares rose by more than 5% in recent Friday trading after the Australian company said it was developing its "most advanced risk-assessment test" for serious diseases.

The test will include more than 200 high-penetrant genes and will allow doctors to identify nearly100% of people at risk of disease going beyond family history, which is only responsible for 5% to 15%. The company said the test includes sporadic nonhereditary disease, which is tied to the remaining 85% of people.

Genetic Technologies' ( GENE ) shares were 5.2% higher at $2.65 in recent trading.

Price: 2.65, Change: +0.13, Percent Change: +5.21